查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1663438

基于人工智慧的数位病理学市场，按神经网路、按组件、按应用、按最终用途、按国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

AI-based Digital Pathology Market, By Neural Network, By Component, By Application, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 381 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年基于人工智慧的数位病理学市场规模价值为 8,560 万美元，2025 年至 2032 年的复合年增长率为 15.80%。

基于人工智慧的数位病理学市场-市场动态

个人化医疗需求不断成长

由于个人化医疗的需求不断增长，基于人工智慧的数位病理学市场预计未来将会成长。根据每位病人独特的需求、喜好和特征量身订做医疗和治疗被称为个人化医疗。个人化医疗变得越来越必要，透过根据每个患者独特的基因特征、生活方式选择和疾病特征量身定制治疗来提高疗效并减少副作用。透过更准确、更有效地分析基因资料和医学影像，基于人工智慧的数位病理学可以实现更精确的诊断、更好地识别疾病亚型以及製定适合每位患者特定生物学特征的客製化治疗方案，从而支持个人化医疗。例如，美国专业会员组织个人化医疗联盟于 2023 年 2 月发布的一份报告指出，2022 年批准了 12 种新的个人化药物，约占所有新疗法的 34%，与前几年相比有显着增长。因此，由于对客製化治疗的需求不断增长，基于人工智慧的数位病理学市场正在扩大。

基于人工智慧的数位病理学市场-关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 15.80%

根据神经网路细分，预计卷积神经网路 (CNN) 将在 2024 年占据最大市场份额

根据应用细分，药物发现是 2024 年的领先领域

根据最终用途细分，医院和参考实验室是 2024 年的主要细分市场

从地区来看，亚太地区是 2024 年最大的收入来源

基于人工智慧的数位病理学市场-細項分析：

全球基于人工智慧的数位病理学市场根据神经网路、组件、应用、最终用途和地区进行细分。

根据组件，市场分为扫描器和软体。 2024 年，由于人工智慧软体在数位病理学中的应用越来越多，软体类别将占据市场主导地位，而病理学家的时间、准确性和结果速度的下降推动了这一趋势，使医生能够评估患者的健康状况并快速安排恢復药物。此外，人工智慧可有效用于储存患者健康资料并检索结果，这将在研究期间增加对基于人工智慧的数位病理学软体的需求。

根据最终用途，市场分为医院和参考实验室、製药和生物技术公司以及学术和研究机构。 2024 年，医院和参考实验室类别占据主导市场。医院和参考实验室每天可能会处理越来越多的病理相关病例。病理学工作负担越来越重，需要使用人工智慧，因为它能够产生可靠的结果，并且节省时间。此外，借助人工智慧，医院可以减少处理更多病例所需的病理学家数量。这将为未来几年全球基于人工智慧的数位病理学市场的成长进一步开闢新的途径。

基于人工智慧的数位病理学市场-地理洞察

2024 年，亚太地区在全球基于人工智慧的数位病理学市场中占据主导地位。由于人工智慧在中国和印度等发展中国家的医疗保健领域的应用不断扩大，基于人工智慧的数位病理学市场正在扩大。根据 NASSCOM 的数据，到 2025 年，印度医疗保健 AI 市场预计将以 40% 的复合年增长率扩张。这表明人工智慧在医学领域的应用日益广泛，由于人工智慧能够快速完成重复任务并节省病理学家的时间，因此可以促进其在病理学中的应用。由于人工智慧可以完成一些与病理学家相关的职责，该领域的低阶病理学家的存在正在推动医疗保健从业者使用它，从而增加了研究期间对它的需求。

然而，在整个预测期内，由于远距医疗的使用日益增多，预计北美地区的复合年增长率将最快。由于严格的封锁要求，COVID-19 鼓励使用远距医疗代替面对面诊疗。美国卫生与公众服务部称，自疫情爆发以来，美国健保受益人使用远距医疗的频率已提高。在美国，2020 年面对面就诊次数为 9.89 亿次，高于 2019 年的 11 亿次。

基于人工智慧的数位病理学市场-竞争格局：

DoMore Diagnostics AS、Aiforia Technologies、Aiosyn、Deep Bio、F. Hoffmann-La Roche 等基于人工智慧的数位病理学市场的领先企业正专注于创造尖端产品，例如先进的癌症检测仪器，以提高患者的治疗效果、加快流程并提高诊断精度。人工智慧驱动的先进癌症检测工具使用深度学习模型和机器学习演算法来评估病理切片和医学影像，提高肿瘤识别和分类的准确性。例如，2022 年 2 月，Crosscope Inc. 和 MindPeak GmbH 合作，将 MindPeak 的影像分析工具纳入 Crosscope 的数位病理学平台。此次合作提升了 Crossscope 的 AI 能力，使其能够提供完整的数位病理学解决方案。透过顺利整合尖端的 AI 工具，此次合作旨在简化组织病理学工作流程，帮助病理学家提高实验室生产力，并为 ER、PR 和 Ki-67 IHC 分析提供及时且重要的诊断。预计整合后患者的治疗效果将会改善。

近期发展

2024 年 1 月：罗氏宣布已完成一项合併协议，收购位于加州柏克莱的美国私人企业 Carmot Therapeutics, Inc.（「Carmot」）。 Carmot 的研究和开发组合包括一系列临床前研究和临床阶段的口服和皮下肠促胰岛素，具有治疗糖尿病和非糖尿病患者肥胖症的最佳潜力。

2023 年 10 月：在云端服务供应商 Amazon Web Services, Inc. 的协助下，F. Hoffmann-La Roche Ltd. 和 Ibex Medical Analytics Ltd. 合作提供人工智慧癌症侦测解决方案。透过 Navify Digital Pathology 软体平台，此次合作旨在为病理实验室提供 Ibex 的人工智慧驱动决策支援功能。临床医生可以透过这种整合获得诊断前列腺癌和乳癌的帮助。

2023 年 9 月：在欧洲、加拿大和亚太市场，Hologic, Inc. 和拜耳股份公司联手提供增强乳房 X 光摄影 (CEM) 解决方案，以便更好地检测乳癌。透过整合拜耳和 Hologic 的技术，该联盟希望能够在乳房 X 光检查期间更轻鬆地应用造影剂。此次合作的主要目的是为放射科医生提供完整的产品包、实践指导和顺畅的 CEM 工作流程整合。

2023 年 6 月：美国数位和计算病理学解决方案供应商 Proscia Inc. 与 MindPeak GmbH 合作。透过紧密协调的人工智慧工作流程，此次合作旨在帮助病理学家得出更有效、更有知识、可重复的临床结论。目标是让癌症患者更有机会获得更好的诊断。

目录

第 1 章：基于人工智慧的数位病理学市场概述

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 基于人工智慧的数位病理学市场片段（按神经网路）
    • 基于人工智慧的数位病理学市场片段（按组件）
    • 基于人工智慧的数位病理学市场片段（按应用）
    • 基于人工智慧的数位病理学市场片段（按最终用途划分）
    • 各国基于人工智慧的数位病理学市场片段
    • 基于人工智慧的数位病理学市场片段（按地区）
  • 竞争洞察

第 3 章：基于人工智慧的数位病理学关键市场趋势

  • 基于人工智慧的数位病理学市场驱动因素
    • 市场驱动因素的影响分析
  • 基于人工智慧的数位病理学市场限制
    • 市场限制的影响分析
  • 基于人工智慧的数位病理学市场机会
  • 基于人工智慧的数位病理学市场未来趋势

第 4 章：基于人工智慧的数位病理学产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：基于人工智慧的数位病理学市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠肺炎疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长领域
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基于人工智慧的数位病理学市场格局

  • 2024 年基于人工智慧的数位病理学市场份额分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：基于人工智慧的数位病理学市场 - 按神经网络

  • 概述
    • 透过神经网路进行细分份额分析
    • 生成对抗网路（GANS）
    • 循环神经网路 (RNN)
    • 卷积神经网路 (CNN)
    • 其他的

第 8 章：基于人工智慧的数位病理学市场 - 按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 扫描仪
    • 软体

第 9 章：基于人工智慧的数位病理学市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 药物研发
    • 临床工作流程
    • 培训与教育
    • 疾病诊断与预后

第 10 章：基于人工智慧的数位病理学市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 医院和参考实验室
    • 製药及生技公司
    • 学术及研究机构

第 11 章：基于人工智慧的数位病理学市场-按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美基于人工智慧的数位病理学主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按神经网路）
    • 北美市场规模及预测（按组件划分）
    • 北美市场规模与预测，按应用划分
    • 北美市场规模和预测，按最终用途
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基于人工智慧的数位病理学主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模及预测（透过神经网路）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测，按最终用途
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基于人工智慧的数位病理学主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太市场规模及预测（依神经网路）
    • 亚太市场规模及预测（按组成部分）
    • 亚太市场规模及预测（按应用划分）
    • 亚太市场规模及预测（依最终用途划分）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基于人工智慧的数位病理学主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（透过神经网路）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模与预测，按应用划分
    • 拉丁美洲市场规模及预测（依最终用途划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲基于人工智慧的数位病理学主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（神经网路）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按应用划分）
    • 中东和非洲市场规模及预测（按最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 12 章：主要供应商分析-基于人工智慧的数位病理学产业

  • 竞争仪錶板
  • 公司简介
    • DoMore Diagnostics AS
    • Aiforia Technologies
    • Aiosyn
    • Deep Bio
    • F. Hoffmann-La Roche
    • Akoya Biosciences
    • deepPath
    • Hologic
    • Konfoong Biotech International
    • Koninklijke Philips NV
    • 4D Path
    • Lumea
    • Ibex Medical Analytics
    • Indica Labs
    • Mindpeak
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4620

REPORT HIGHLIGHT

AI-based Digital Pathology Market size was valued at US$ 85.6 Million in 2024, expanding at a CAGR of 15.80% from 2025 to 2032.

AI-based digital pathology is a cutting-edge method of using digital technologies and artificial intelligence to diagnose and analyze illnesses. In order to identify patterns, anomalies, and particular disease signs, pathology slides are digitized into high-resolution images and subsequently sent to AI algorithms for analysis. By automating repetitive procedures, increasing diagnostic precision, and spotting minute details that would be overlooked during manual inspection, these AI systems might help pathologists. The AI-based digital pathology market is growing as a result of the growing emphasis on hospital cost control and efficiency enhancement, the rising need for technologically sophisticated solutions, and the rising number of incorrect diagnoses. Additionally, it is anticipated that government-funded research initiatives that support the creation of cutting-edge digital tools for pathology would support the AI-based digital pathology market growth.

AI-based Digital Pathology Market- Market Dynamics

Growing demand for personalized medication

The market for AI-based digital pathology is anticipated to increase in the future due to the growing demand for personalized medication. Customizing medical care and treatment to each patient's unique needs, preferences, and traits is known as personalized medicine. Personalized medicine is becoming more and more necessary in order to improve efficacy and decrease side effects by customizing therapies to each patient's unique genetic profile, lifestyle choices, and illness features. By making it possible to analyze genetic data and medical images more accurately and efficiently, AI-based digital pathology supports personalized medicine by facilitating more precise diagnosis, improved identification of disease subtypes, and customized treatment regimens that fit each patient's particular biological profile. For instance, a report released in February 2023 by the US-based professional membership organization Personalized Medicine Coalition stated that the approval of 12 new personalized medications in 2022-roughly 34% of all new therapies-represented a notable increase over prior years. Thus, the market for AI-based digital pathology is expanding due to the growing demand for tailored therapy.

AI-based Digital Pathology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.80% over the forecast period (2025-2032)

Based on neural network segmentation, the convolutional neural networks (CNNs) were predicted to show maximum market share in the year 2024

Based on application segmentation, drug discovery was the leading segment in 2024

Based on end use segmentation, hospitals & reference laboratories were the leading segment in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

AI-based Digital Pathology Market- Segmentation Analysis:

The Global AI-based Digital Pathology Market is segmented on the basis of Neural Network, Component, Application, End Use, and Region.

On the basis of component, the market is segregated into Scanners and Software. In 2024, the market was dominated by the software category due to the increasing use of artificial intelligence software in digital pathology, which has been fueled by a decrease in pathologists' time, accuracy, and speed of results, enabling physicians to assess a patient's health and schedule recovery medication rapidly. Additionally, AI may be used effectively to store patient health data and retrieve results, which will increase the demand for AI-based digital pathology software during the study period.

Based on end use, the market is divided into Hospitals & Reference Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. In 2024, the hospitals & reference laboratories category held a dominant market share. Hospitals and reference labs will probably deal with an increasing number of pathology-related cases every day. The increasing burden for pathology jobs will need the use of AI due to its ability to produce reliable results and its time-saving capabilities. Additionally, hospitals can reduce the number of pathologists they require to manage more cases thanks to AI. This will further open up new avenues for the global AI-based digital pathology market to grow in the years to come.

AI-based Digital Pathology Market- Geographical Insights

In 2024, Asia-Pacific held a dominant position in the global market for AI-based Digital Pathology. The market for AI-based digital pathology is expanding due to the expanding application of AI in healthcare sectors in developing nations like China and India. By 2025, the healthcare AI market in India is anticipated to expand at a 40% CAGR, according to NASSCOM. This illustrates the growing usage of AI in the medical field, which could encourage its application in pathology due to its speedy completion of repetitive tasks and capacity to save pathologists time. Because artificial intelligence can do some pathologist-related duties, the presence of lower-level pathologists in the area is pushing healthcare practitioners to use it, increasing demand for it during the research period.

However, throughout the projected period, the North America region is anticipated to see the fastest CAGR because of the growing use of telemedicine. Due to strict lockdown requirements, COVID-19 encouraged the use of telemedicine instead of in-person sessions. Medicare beneficiaries in the US have been using telemedicine more frequently since the epidemic, according to the US Department of Health and Human Services. In the United States, there were 989 million in-person medical visits in 2020, up from 1.1 billion in 2019. By 2020, there were almost 52.7 million telemedicine appointments, up from 8,40,000 in 2019. AI-based technologies that assist physicians in treating patients remotely will be required as this trend, which is anticipated to increase due to decreased transaction costs, develops.

AI-based Digital Pathology Market- Competitive Landscape:

Leading players in the AI-based digital pathology market, such as DoMore Diagnostics AS, Aiforia Technologies, Aiosyn, Deep Bio, F. Hoffmann-La Roche, and others, are concentrating on creating cutting-edge products, such as sophisticated cancer detection instruments to boost patient outcomes, expedite processes, and increase diagnostic precision. AI-powered advanced cancer detection tools use deep learning models and machine learning algorithms to evaluate pathology slides and medical images, improving the precision of tumour identification and classification. For instance, in February 2022, Crosscope Inc. and MindPeak GmbH partnered to include MindPeak's image analysis tools into Crosscope's Digital Pathology platform. Crosscope's AI capabilities are improved by this collaboration, allowing them to offer complete digital pathology solutions. Through the smooth integration of cutting-edge AI tools, the collaboration seeks to streamline Histopathology workflows, assisting pathologists in enhancing lab productivity and providing prompt and significant diagnoses for ER, PR, and Ki-67 IHC analysis. Treatment outcomes for patients are expected to improve as a result of the integration.

Recent Development

January 2024: Roche declared that it had finalized a merger deal to buy Berkeley, California-based Carmot Therapeutics, Inc. ("Carmot"), a privately held US business. Carmot's research and development portfolio includes a range of preclinical studies and clinically staged oral and subcutaneous incretins with best-in-class potential to treat obesity in individuals with and without diabetes.

October 2023: With the help of cloud service provider Amazon Web Services, Inc., F. Hoffmann-La Roche Ltd. and Ibex Medical Analytics Ltd. have partnered to offer AI-powered cancer detection solutions. Through the Navify Digital Pathology software platform, this partnership seeks to provide pathology labs with access to Ibex's AI-driven decision support capabilities. Clinicians can get help diagnosing prostate and breast cancer through this integration.

September 2023: In the European, Canadian, and Asia Pacific markets, Hologic, Inc. and Bayer AG have teamed together to offer contrast-enhanced mammography (CEM) solutions for better breast cancer detection. By combining Bayer and Hologic's technology, the alliance hopes to make it easier to apply contrast media during mammography exams. The collaboration is centred on offering radiologists complete product bundles, practical instruction, and smooth CEM workflow integration.

June 2023: Proscia Inc., a U.S.-based supplier of digital and computational pathology solutions, has partnered with MindPeak GmbH. Through closely coordinated AI-powered workflows, this collaboration seeks to assist pathologists in reaching more effective, knowledgeable, and repeatable clinical conclusions. The objective is to increase cancer patients' access to better diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • DoMore Diagnostics AS
  • Aiforia Technologies
  • Aiosyn
  • Deep Bio
  • F. Hoffmann-La Roche
  • Akoya Biosciences
  • deepPath
  • Hologic
  • Konfoong Biotech International
  • Koninklijke Philips N.V.
  • 4D Path
  • Lumea
  • Ibex Medical Analytics
  • Indica Labs
  • Mindpeak
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY NEURAL NETWORK- MARKET ANALYSIS, 2019 - 2032

  • Generative adversarial networks (GANS)
  • Recurrent neural networks (RNNs)
  • Convolutional neural networks (CNNs)
  • Others

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Scanners
  • Software

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Drug Discovery
  • Clinical Workflow
  • Training & Education
  • Disease Diagnosis & Prognosis

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Reference Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

GLOBAL AI-BASED DIGITAL PATHOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Digital Pathology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Digital Pathology Market Snippet by Neural Network
    • 2.1.2. AI-based Digital Pathology Market Snippet by Component
    • 2.1.3. AI-based Digital Pathology Market Snippet by Application
    • 2.1.4. AI-based Digital Pathology Market Snippet by End Use
    • 2.1.5. AI-based Digital Pathology Market Snippet by Country
    • 2.1.6. AI-based Digital Pathology Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Digital Pathology Key Market Trends

  • 3.1. AI-based Digital Pathology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Digital Pathology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Digital Pathology Market Opportunities
  • 3.4. AI-based Digital Pathology Market Future Trends

4. AI-based Digital Pathology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Digital Pathology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Digital Pathology Market Landscape

  • 6.1. AI-based Digital Pathology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Digital Pathology Market - By Neural Network

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Neural Network, 2024 & 2032 (%)
    • 7.1.2. Generative adversarial networks (GANS)
    • 7.1.3. Recurrent neural networks (RNNs)
    • 7.1.4. Convolutional neural networks (CNNs)
    • 7.1.5. Others

8. AI-based Digital Pathology Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 8.1.2. Scanners
    • 8.1.3. Software

9. AI-based Digital Pathology Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Drug Discovery
    • 9.1.3. Clinical Workflow
    • 9.1.4. Training & Education
    • 9.1.5. Disease Diagnosis & Prognosis

10. AI-based Digital Pathology Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Reference Laboratories
    • 10.1.3. Pharmaceutical & Biotechnology Companies
    • 10.1.4. Academic & Research Institutes

11. AI-based Digital Pathology Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. AI-based Digital Pathology Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. AI-based Digital Pathology Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. AI-based Digital Pathology Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. AI-based Digital Pathology Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. AI-based Digital Pathology Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Neural Network, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- AI-based Digital Pathology Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. DoMore Diagnostics AS
    • 12.2.2. Aiforia Technologies
    • 12.2.3. Aiosyn
    • 12.2.4. Deep Bio
    • 12.2.5. F. Hoffmann-La Roche
    • 12.2.6. Akoya Biosciences
    • 12.2.7. deepPath
    • 12.2.8. Hologic
    • 12.2.9. Konfoong Biotech International
    • 12.2.10. Koninklijke Philips N.V.
    • 12.2.11. 4D Path
    • 12.2.12. Lumea
    • 12.2.13. Ibex Medical Analytics
    • 12.2.14. Indica Labs
    • 12.2.15. Mindpeak
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us